Cymabay Therapeutics Inc

NASDAQ:CBAY   10:01:00 AM EDT
3.25
-0.03 (-0.92%)
Earnings Announcements

Cymabay Reports Posts Quarterly Loss Per Share Of 33 Cents

Published: 11/10/2021 22:34 GMT
Cymabay Therapeutics Inc (CBAY) - Cymabay Reports Third Quarter and Nine Months Ended September 30, 2021 Financial Results and Provides Corporate Update.
Cymabay Therapeutics Inc Qtrly Loss per Share 33 Cents.
Revenue is expected to be $5.63 Million
Adjusted EPS is expected to be -$0.27

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.36

More details on our Analysts Page.